Just want to point out this covid trial hasn't been stopped for futility like has been said by a number of posters. They have been advised to continue to completion, so imo there must be some positive signs re secondary endpoints and maybe some mortality benefit (just not enough to pass primary endpoint)
Hopefully enough positive data is gained to keep Novartis partnership.
Ann: Mesoblast Update on COVID-19 ARDS Trial, page-356
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
-0.025(2.23%) |
Mkt cap ! $1.250B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.16 | $1.04 | $14.57M | 13.49M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 21024 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 241 | 1 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |